Robert Bullis

Title: Innovations by Robert Bullis in Biopharmaceutical Production

Introduction

Robert Bullis is an accomplished inventor based in Ellicott City, MD (US). He has made significant contributions to the field of biopharmaceuticals, holding two patents that focus on innovative production systems using crustaceans and rotifers. His work aims to enhance the efficiency and cost-effectiveness of therapeutic protein production.

Latest Patents

Bullis's latest patents include "Crustaceans as production systems for therapeutic proteins" and "Transfected shrimp as production systems for therapeutic proteins." Both patents describe a method where a crustacean or rotifer is infected with a recombinant infectious virus that expresses a protein exogenous to the virus. Importantly, the genome of the crustacean or rotifer remains unaltered. The transcription of a gene inserted into the recombinant virus genome is driven by crustacean, rotifer, insect, or viral promoters, allowing the virus to replicate in the cell cytoplasm. The infected organisms can be provided directly to humans or non-human animals, or after production and harvest, purified recombinant proteins can be extracted. This innovative production system allows for the rapid and inexpensive generation of large quantities of biopharmaceuticals.

Career Highlights

Robert Bullis is associated with Advanced Bionutrition Corporation, where he continues to develop groundbreaking technologies in the field of biopharmaceuticals. His work has positioned him as a key figure in the advancement of therapeutic protein production.

Collaborations

Some of his notable coworkers include Ruth Barratt and F C Thomas Allnutt, who have collaborated with him on various projects within the company.

Conclusion

Robert Bullis's innovative patents and contributions to biopharmaceutical production highlight his role as a leading inventor in the field. His work not only advances scientific knowledge but also has the potential to significantly impact the healthcare industry.